The Natural Solution for Vision Correction
Because we use allograft tissue, our implants can be right beneath the surface of the eye—making our treatment the least invasive of all refractive procedures.
Allotex Inc. is an ophthalmic biologics and device company developing new therapeutic solutions for the treatment of presbyopia, hyperopia, and myopia. The therapy is accomplished through tissue addition technology that uses precisely-shaped human corneal allografts to create what is essentially a permanent, living contact lens or lens insert.
Allotex is a start-up company founded by Drs. Michael Mrochen and David Muller.